Equities

Roivant Sciences Ltd

Roivant Sciences Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)12.43
  • Today's Change0.605 / 5.12%
  • Shares traded7.84m
  • 1 Year change+38.06%
  • Beta1.2324
Data delayed at least 15 minutes, as of Nov 22 2024 20:21 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income4,231(1115)(924)
Depreciation/depletion2219--
Non-Cash items(5038)247217
Cash taxes paid, supplemental12----
Cash interest paid, supplemental105.130.92
Changes in working capital196.3530
Total cash from operations(765)(843)(678)
INVESTING
Capital expenditures(1.38)(13)(17)
Other investing and cash flow items, total5,205(32)321
Total cash from investing5,204(44)303
FINANCING
Financing cash flow items(44)(13)292
Total cash dividends paid------
Issuance (retirement) of stock, net4943830
Issuance (retirement) of debt, net(31)13015
Total cash from financing419499307
NET CHANGE IN CASH
Foreign exchange effects0.626.28--
Net change in cash4,858(382)(68)
Net cash-begin balance/reserved for future use1,6922,0742,142
Net cash-end balance/reserved for future use6,5501,6922,074
SUPPLEMENTAL INCOME
Depreciation, supplemental2219--
Cash interest paid, supplemental105.130.92
Cash taxes paid, supplemental12----
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.